| Nina Yu Wen, AA | |
|
6431 Fannin St, Houston, TX 77030-1501 | |
| (713) 500-5116 | |
| Not Available |
| Full Name | Nina Yu Wen |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 6 Years |
| Location | 6431 Fannin St, Houston, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801374343 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 26187254 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann - Texas Medical Center | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ut Physicians | 8426960360 | 1400 |
News Archive
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.
About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold that gives tissues their structure.
Scientists at Cold Spring Harbor Laboratory have identified a therapeutic RNA molecule that corrects the error in genetic processing that leads to familial dysautonomia, a rare inherited neurodegenerative disorder.
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.
› Verified 1 days ago
| Entity Name | U S Anesthesia Partners Of Texas, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548208564 PECOS PAC ID: 7315850351 Enrollment ID: O20031106000563 |
News Archive
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.
About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold that gives tissues their structure.
Scientists at Cold Spring Harbor Laboratory have identified a therapeutic RNA molecule that corrects the error in genetic processing that leads to familial dysautonomia, a rare inherited neurodegenerative disorder.
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.
› Verified 1 days ago
| Entity Name | Ut Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033157821 PECOS PAC ID: 8426960360 Enrollment ID: O20031107000268 |
News Archive
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.
About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold that gives tissues their structure.
Scientists at Cold Spring Harbor Laboratory have identified a therapeutic RNA molecule that corrects the error in genetic processing that leads to familial dysautonomia, a rare inherited neurodegenerative disorder.
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nina Yu Wen, AA 6431 Fannin St, Houston, TX 77030-1501 Ph: () - | Nina Yu Wen, AA 6431 Fannin St, Houston, TX 77030-1501 Ph: (713) 500-5116 |
News Archive
An experimental drug that attacks brain tumor tissue by crippling the cells' energy source called the mitochondria has passed early tests in animal models and human tissue cultures, say Houston Methodist scientists.
About 90 percent of cancer deaths are caused by tumors that have spread from their original locations. This process, known as metastasis, requires cancer cells to break loose from their neighbors and from the supportive scaffold that gives tissues their structure.
Scientists at Cold Spring Harbor Laboratory have identified a therapeutic RNA molecule that corrects the error in genetic processing that leads to familial dysautonomia, a rare inherited neurodegenerative disorder.
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
NanoViricides, Inc. announced today that the European Medicines Agency, has awarded orphan drug designation to DengueCide, the Company's drug candidate for the treatment of dengue and dengue hemorrhagic fever.
› Verified 1 days ago
James Nast Trahan, AA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1500 Citywest Blvd Ste 300, Houston, TX 77042 Phone: 713-620-4000 | |
Caitlyn Marie Kohake, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 6720 Bertner Ave, Houston, TX 77030 Phone: 823-355-2666 | |
Robert Sean Mcneill, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd, Ste. 300, Houston, TX 77042 Phone: 713-620-4000 Fax: 713-458-4229 | |
Aleena A Gillani, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd Ste 300, Houston, TX 77042 Phone: 972-233-1999 Fax: 972-233-3666 | |
Logan Patrick Fettig, Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 6720 Bertner Ave, Houston, TX 77030 Phone: 832-355-2666 | |
Joseph Grant Shafer, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 6414 Fannin St, #g125, Houston, TX 77030 Phone: 713-500-6930 Fax: 713-500-5484 | |
Sarah P Her, AA-S Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 1500 Citywest Blvd, Ste. 300, Houston, TX 77042 Phone: 713-620-4000 Fax: 713-458-4229 |